Breaking
European Research Revolution: Day 1 HighlightsRAPS Euro Convergence: Key Regulatory Updates - Day 1Cellenkos Receives FDA Clearance for CK0802 Phase 2a Trial in Steroid-Refractory GVHD
🇺🇸 FDA

Antiviral

Page 1 • 1 item

Global antiviral market intelligence for pharma BD, investors & analysts. Track drug development, regulatory approvals & M&A in infectious disease.

Aicuris Receives FDA Priority Review for Pritelivir, Novel Herpes Treatment for Immunocompromised Patients
NewsAntiviral - Herpes Simplex Virus InfectionsApr 17, 2026

Aicuris Receives FDA Priority Review for Pritelivir, Novel Herpes Treatment for Immunocompromised Patients

FDA grants Priority Review for Aicuris' pritelivir NDA, targeting resistant herpes infections in immunocompromised patients with Q4 2026 PDUFA date.

Dr. Sarah Mitchell